Topline

TOPLINE

Aims Apac Reit eyes data centre growth as it expands beyond industrial assets

Government endorsement for two Sydney sites gives the manager the option to develop them into data centre assets

Lim Tze Chiang, chairman and executive director of noodlemaker Leong Guan, sees its 2025 listing as the start of a new growth chapter.
TOPLINE

‘Three months to decide, three years to list’: Singapore noodlemaker Leong Guan eyes growth after IPO

The company is aiming for new acquisitions and export markets among its post-listing goals

Concord New Energy's Mike Luo urges investors to view the company as being at the intersection of AI and the physical world.

Concord New Energy seeks to ride AI power boom after bruising year in China

The company is also evaluating a Reit issuance, with Singapore as a potential market

After a decade at the helm, ST Engineering chief Vincent Chong believes "the best is yet to come" for the group.
TOPLINE

More than a defence contractor – ST Engineering’s Vincent Chong is ready for the next lap

To see the group as a mere defence proxy cashing in on conflict misses the plot entirely

Snowflake is riding the AI wave internally and externally with customers, said CEO Sridhar Ramaswamy.

AI drives NYSE-listed Snowflake’s revenue growth, productivity as cloud data demand surges

Increasing focus on artificial intelligence is driving sales and changing how clients interact with the platform

Thomas Laboulle, founder and CEO of Toku, says starting the company was not a eureka moment, but the result of a series of observations over time.
TOPLINE

Catalist-listed Toku makes enterprise AI push as it pursues growth over near-term profit

The company sees strong demand for the technology aligning with its expansion across global markets

Eva Tan, chief commercial officer, and Eddy Lee,  chairman and chief executive officer of IX Biopharma; the company wants to lead the world in longevity
TOPLINE

Singapore-listed iX Biopharma bets big on non-opioid pain relief

Its flagship drug Wafermine is a sublingual ketamine wafer that delivers rapid pain relief without addiction risks

Haim Brosh, executive director and CEO at The Trendlines Group, is leading a strategic pivot aimed at streamlining operations.
TOPLINE

Now back in the black, SGX-listed Trendlines doubles down on core bets

The group is concentrating on assets in its strongest portfolio companies, says CEO Haim Brosh

Han Khim Siew, CEO of OUE Reit's manager, says disciplined capital recycling and portfolio optimisation could drive the Reit's stock price and DPU growth.
TOPLINE

OUE Reit looks to unlock value in mature assets, eyes Sydney for higher-yield growth

Proceeds from a potential One Raffles Place sale could fund its further expansion in Sydney’s Salesforce Tower

Marex's Asia-Pacific revenue has more than quadrupled from US$27 million in 2021 to US$131 million in 2024 – outpacing growth in other regions.
TOPLINE

Nasdaq-listed Marex plans more acquisitions, with new Japan office to expand Asia-Pacific presence

Amid geopolitical uncertainty, the firm is being ‘more proactive’ with clients